Competitor Analysis: Interleukin-1 (IL-1) Inhibitors and IL-1 Receptor (IL-1R) Antagonists

Publisher: La Merie Publishing
Pages: 22
Format: PDF
Product Line:
Competitor Analysis
Product Line:
Target Pipeline
Product Code: LMCA0048
Release Date: July of 2012

150.00 €
Free of 19 % VAT (except in Germany and also in the European Union without valid intl. VAT no),
Delivery costs do not apply or are included.
License:
You can also order this product via email or fax , please download the Order Form
Need more information?
Ask a question about this product

Competitor Analysis: Interleukin-1 (IL-1) Inhibitors and IL-1 Receptor (IL-1R) Antagonists

Product description

The present Competitive Intelligence Report about Interleukin-1 (IL-1) Inhibitors and IL-1 Receptor (IL-1R) Antagonists for treatment of rheumatoid arthritis, diabetes, gout, COPD and other autoimmune/inflammatory conditions provides a competitor evaluation in the field of R&D projects with Interleukin-1 (IL-1) Inhibitors and Receptor (IL-1R) Antagonists as of July 2012. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report.

The report includes a compilation of currently active projects in research and development of interleukin-1 (IL-1) inhibitors and IL-1 receptor (IL-1R) antagonists. In addition, the report lists company-specific R&D pipelines of IL-1/R antagonists. Competitor projects are listed in a tabular format providing information on:

  • Drug Codes,
  • Target / Mechanism of Action,
  • Class of Compound,
  • Company
  • Product Category/Therapeutic Area
  • Indication,
  • R&D Stage and
  • Additional comments with a hyperlink leading to the source of information.

About Competitor Analysis Series:

The Competitor Analysis Series delivers NO-FRILLS, but concise information about the pipeline of R&D projects for targets, diseases, technologies and companies at low prices. The information is provided in a tabular format and fully referenced.

 

Competitor Analysis: Interleukin-1 (IL-1) Inhibitors and IL-1 Receptor (IL-1R) Antagonists

  • Ilaris Pipeline
  • Gevokizumab Pipeline
  • Novel IL-1 Inhibitors and IL-1R Antagonists
  • Corporate IL-1/R Antagonist R&D Pipelines



The above shown price refers to a Single User License. Please contact us for prices of departmental, site or global product licenses.

This Report is NOT a downloadable item but will be delivered via email within 24 h (working days only).

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2018 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top